Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dose Schedule Study”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT00726232
What this trial is testing

Study to Determine the Safety and Efficacy of INCB018424 in Patients With Polycythemia Vera or Essential Thrombocythemia

Who this might be right for
Myeloproliferative Neoplasm (MPN)
Incyte Corporation 73
Large-scale testing (Phase 3)Study completedNCT00418717
What this trial is testing

Open Label, Dose-Regimen Study Evaluating Etanercept 50 mg Once-Weekly In Japanese Subjects With RA

Who this might be right for
Arthritis, Rheumatoid
Wyeth is now a wholly owned subsidiary of Pfizer 42
Early research (Phase 1)Ended earlyNCT01602627
What this trial is testing

Hsp90 Inhibitor AUY922 in Treating Older Patients With Advanced Solid Malignancies

Who this might be right for
Unspecified Adult Solid Tumor, Protocol Specific
Dale Shepard, MD, PhD 2
Large-scale testing (Phase 3)Study completedNCT04908722
What this trial is testing

Evaluate Dose Levels of Ad26.COV2.S Administered as a Two-dose Schedule in Healthy Adults

Who this might be right for
COVID-19 Prevention
Janssen Vaccines & Prevention B.V. 1,609
Testing effectiveness (Phase 2)Study completedNCT00169481
What this trial is testing

A Study in Children With Different Formulations of GSK Biologicals' 11 Valent Pneumococcal Conjugate Vaccine

Who this might be right for
Streptococcal Infections
GlaxoSmithKline 689
Large-scale testing (Phase 3)Study completedNCT02027207
What this trial is testing

Single Dose Oral Cholera Vaccine Study in Dhaka, Bangladesh

Who this might be right for
Cholera
International Centre for Diarrhoeal Disease Research, Bangladesh 204,438
Early research (Phase 1)Study completedNCT04026009
What this trial is testing

Safety and Immunogenicity Study of GSK's Clostridium Difficile Vaccine 2904545A When Administered in Healthy Adults Aged 18-45 Years and 50-70 Years

Who this might be right for
Clostridium Infections
GlaxoSmithKline 140
Large-scale testing (Phase 3)Study completedNCT00657644
What this trial is testing

Efficacy and Safety of Vardenafil in Men With Erectile Dysfunction

Who this might be right for
Erectile Dysfunction
Bayer 130
Large-scale testing (Phase 3)Study completedNCT01252940
What this trial is testing

Study to Evaluate Switching From Regimens Consisting of a Ritonavir-boosted Protease Inhibitor (PI) and Two Nucleoside Reverse Transcriptase Inhibitors (NRTIs) to a Fixed-dose Tablet Containing Emtricitabine/Rilpivirine/Tenofovir DF

Who this might be right for
HIV-1 Infection
Gilead Sciences 482
Testing effectiveness (Phase 2)Study completedNCT02664103
What this trial is testing

Study of Capecitabine and Cyclophosphamide Administered as a Single Pill in Patients With Advanced Breast Cancer

Who this might be right for
Breast Cancer Metastatic
Sanofi 2
Early research (Phase 1)Study completedNCT00006279
What this trial is testing

The Safety of Nevirapine When Given to Breast-Feeding Babies From Birth to Age 6 Months

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 75
Testing effectiveness (Phase 2)Study completedNCT03849105
What this trial is testing

131I-IPA and Concurrent XRT in Recurrent GBM

Who this might be right for
Glioblastoma Multiforme
Telix Pharmaceuticals (Innovations) Pty Limited 10
Post-approval studies (Phase 4)Study completedNCT01059266
What this trial is testing

PURETHAL Grasses Rush Study

Who this might be right for
Allergic RhinitisAllergic Rhinoconjunctivitis
HAL Allergy 150
Testing effectiveness (Phase 2)Ended earlyNCT00133484
What this trial is testing

UMD rPA Regimen Trial in Adults

Who this might be right for
Bacillus Anthracis (Anthrax)
National Institute of Allergy and Infectious Diseases (NIAID) 270
Large-scale testing (Phase 3)Study completedNCT00338117
What this trial is testing

Safety and Efficacy of High Dose, Rapid Titration Galantamine in Patients With Alzheimer's Disease

Who this might be right for
Alzheimer's DiseaseDementia
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 554
Early research (Phase 1)Study completedNCT01041235
What this trial is testing

Safety Study of a Liposomal Docetaxel Formulation in Patients With Solid Tumors Who Have Failed Previous Therapies

Who this might be right for
Solid TumorBreast CancerOvarian Cancer+2 more
Azaya Therapeutics, Inc. 29
Early research (Phase 1)Active Not RecruitingNCT07584668
What this trial is testing

Safety, Tolerability and Pharmacokinetics of EM-I-2024

Who this might be right for
Assess the Safety and Tolerability of Various Doses and Dosing Schedules of EnteroMix in Patients With a Histologically Confirmed Solid Tumor
National Medical Research Radiological Centre of the Ministry of Health of Russia 24
Testing effectiveness (Phase 2)Study completedNCT03036384
What this trial is testing

Estimation of the ED95 of Intrathecal Hyperbaric Prilocaine 2% With Sufentanyl for Scheduled Cesarean Delivery

Who this might be right for
Pregnant Women
Centre Hospitalier Universitaire Saint Pierre 40
Post-approval studies (Phase 4)Study completedNCT00156078
What this trial is testing

Evaluate Pregabalin In Patients With Painful Diabetic Peripheral Neuropathy (DPN)

Who this might be right for
Diabetic Neuropathy, Painful
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 450
Post-approval studies (Phase 4)Study completedNCT04869982
What this trial is testing

Efficacy, Immunogenicity and Safety Study of GSKs Recombinant Zoster Vaccine Shingrix (GSK1437173A) in Chinese Adults Aged ≥50 Years

Who this might be right for
Herpes Zoster
GlaxoSmithKline 6,138
Next Page